Published in Biochem Soc Trans on November 01, 1997
Activation of hepatic lipase expression by oleic acid: possible involvement of USF1. Nutrients (2009) 0.78
Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65
Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem (1973) 3.69
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem (1998) 1.44
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care (1998) 1.38
Contribution of hyperoxia to lipid peroxidation in coronary artery operations: should we keep a low oxygen tension? J Thorac Cardiovasc Surg (1997) 1.38
The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care (1998) 1.28
Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20
Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) (1983) 1.18
Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) (1997) 1.11
Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol (1989) 1.10
Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis (2001) 1.06
Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey. Arch Emerg Med (1989) 1.04
Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) (1987) 1.03
The genito-urinary manifestations of herpes zoster. Three case reports and a review of the literature. Br J Urol (1974) 1.02
Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med (1988) 1.00
The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes (1985) 0.99
The effect of heparin in vitro on human plasm post-heparin lipolytic activity. Clin Chim Acta (1975) 0.95
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care (2000) 0.93
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy. Postgrad Med J (1991) 0.93
Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. Lancet (1968) 0.92
The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study). Diabet Med (2004) 0.91
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med (1991) 0.90
Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care (2001) 0.90
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens (1990) 0.89
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) (1996) 0.88
Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet (1979) 0.87
High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) (2001) 0.87
Evidence for an hepatic anti-ketogenic effect of insulin in man. Clin Sci Mol Med (1978) 0.86
Proceedings: The development of an enzymic technique for the assay of cholesterol in biological fluids. Clin Sci Mol Med (1974) 0.85
Calorie restriction for treatment of gestational diabetes. Diabetes (1991) 0.85
Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous-flow analysis. Clin Chem (1976) 0.85
Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J (1988) 0.85
Myocardial injury in major aortic surgery. J Vasc Surg (2000) 0.85
Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med (2003) 0.84
The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med (1976) 0.84
Heroin and hyperkalaemia. Lancet (1981) 0.84
Serum-insulin in acromegaly. Lancet (1969) 0.83
Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med (1990) 0.82
Lipoprotein lipase in human adipose tissue. Clin Sci Mol Med (1974) 0.82
The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med (1988) 0.82
Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med (1991) 0.82
Arterial wall changes in type 2 diabetic subjects. Diabet Med (1994) 0.82
Prostaglandin E 1 and human platelets. Lancet (1969) 0.81
Abnormalities of glucose tolerance following gestational diabetes. Q J Med (1990) 0.81
Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans (1997) 0.81
Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? Atherosclerosis (2010) 0.81
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart (1999) 0.81
Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Diabet Med (2002) 0.80
Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem (1993) 0.80
High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med (1985) 0.80
The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab (1995) 0.79
Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. Metabolism (2001) 0.79
Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J Clin Endocrinol Metab (1987) 0.79
Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease. Clin Sci Mol Med (1975) 0.79
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabet Med (2001) 0.78
The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia (1978) 0.78
The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat. Diabetes (1977) 0.78
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med (2006) 0.78
The effect of hypolipidaemic therapy on serum uric acid concentration. Atherosclerosis (1976) 0.78
Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens (1988) 0.78
Lipid peroxidation, antioxidant status and troponin-T following cardiopulmonary bypass. A comparison between intermittent crossclamp with fibrillation and crystalloid cardioplegia. Eur J Cardiothorac Surg (1997) 0.78
Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Trans (1995) 0.77
Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab (1997) 0.77
Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet (1971) 0.77
Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol (Oxf) (1998) 0.77
Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta (1982) 0.77
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
Hypertriglyceridaemia and hyperuricaemia. Lancet (1977) 0.77
Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) (1991) 0.76
Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria. Diabet Med (1991) 0.76
Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med (1991) 0.76
Reduced postprandial energy expenditure in women predisposed to type 2 diabetes. Diabet Med (1994) 0.76
Towards a definitive assay of creatinine in serum and in urine: separation by high-performance liquid chromatography. J Chromatogr (1978) 0.76
A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci (Lond) (1991) 0.76
Feedback inhibition of insulin secretion in type 2 diabetes. Clin Sci (Lond) (1991) 0.76
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med (1989) 0.76
Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes. Diabet Med (1994) 0.76
Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med (1986) 0.76